Surmodics DSO Ratio 2011-2026 | SRDX

Annual DSO Ratio Surmodics

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
34.9	29.3	35.8	29.2	32.1	64.8	45	39	38.7	44.1	30.2	34.7	35.6	41.4

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
64.8	29.2	38.2

Quarterly DSO Ratio Surmodics

2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
38.2	39.2	39.4	-	38.7	36	35.5	-	20.8	37.2	37.5	-	20.3	33.3	34.1	-	34	22.5	32.2	31.1	26.1	31.4	33.6	26.6	33.7	37.7	38.2	35.2	36.4	37.3	37.3	32.8	37	36.8	34.4	34.5	31.4	31.8	35.9	39.3	42.9	32.9	29.5	28.3	29.7	33.1	34.3	35.1	34.9	32.5	31.2	32.4	32.4	32.4	30.1	28.8	30.8	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
42.9	20.3	33.4

DSO Ratio of other stocks in the Diagnostics research industry

Issuer	DSO Ratio	Price	% 24h	Market Cap	Country
Centogene N.V. CNTG	145	-	-6.23 %	$ 30.6 M	Germany
Charles River Laboratories International CRL	65	$ 168.22	-3.26 %	$ 8.34 B	USA
Agilent Technologies A	63.8	$ 114.84	-0.55 %	$ 34.9 B	USA
Castle Biosciences CSTL	49.2	$ 24.73	-0.44 %	$ 687 M	USA
Danaher Corporation DHR	55.3	$ 192.12	0.53 %	$ 137 B	USA
DexCom DXCM	87	$ 63.21	1.59 %	$ 24.7 B	USA
Aspira Women's Health AWH	1.17 K	-	-6.19 %	$ 10.5 M	USA
Biocept BIOC	112	-	-13.05 %	$ 7.29 M	USA
Fulgent Genetics FLGT	77.4	$ 16.42	-2.38 %	$ 496 M	USA
Guardant Health GH	46.1	$ 89.66	-4.44 %	$ 11.2 B	USA
Oxford Immunotec Global PLC OXFD	90.8	-	-	$ 562 M	Britain
Akumin AKU	57.4	-	-17.87 %	$ 25.9 M	Canada
ICON Public Limited Company ICLR	68.5	$ 109.62	-4.0 %	$ 9.04 B	Irlanda
CareDx, Inc CDNA	51.5	$ 17.82	-2.68 %	$ 950 M	USA
Illumina ILMN	61.3	$ 127.74	0.28 %	$ 20.3 B	USA
Burning Rock Biotech Limited BNR	31.7	$ 16.3	0.62 %	$ 175 M	China
IQVIA Holdings IQV	73.9	$ 170.72	-1.47 %	$ 29.3 B	USA
Accelerate Diagnostics AXDX	291	-	-61.36 %	$ 2.46 M	USA
Laboratory Corporation of America Holdings LH	52.9	$ 274.46	0.27 %	$ 22.8 B	USA
Lantheus Holdings LNTH	80.5	$ 75.89	-0.28 %	$ 5.12 B	USA
Global Cord Blood Corporation CO	112	-	-	$ 399 M	China
Fluidigm Corporation FLDM	67.2	-	1.08 %	$ 308 M	USA
Genetic Technologies Limited GENE	11.7 K	-	-	$ 7.1 B	Australia
Genetron Holdings Limited GTH	122	-	0.12 %	$ 80.1 M	China
Exact Sciences Corporation EXAS	30.8	-	-	$ 19.8 B	USA
Medpace Holdings MEDP	50.4	$ 496.0	-0.47 %	$ 14.3 B	USA
PRA Health Sciences, Inc. PRAH	98.1	-	-	$ 10.7 B	USA
Mettler-Toledo International MTD	66.4	$ 1 266.63	0.53 %	$ 26.1 B	Schweiz
Myriad Genetics MYGN	52.3	$ 4.67	-1.68 %	$ 432 M	USA
ENDRA Life Sciences NDRA	7.11	$ 4.74	1.07 %	$ 3.73 M	USA
NeoGenomics NEO	77.7	$ 8.02	0.25 %	$ 1.03 B	USA
Neogen Corporation NEOG	66.6	$ 9.56	1.59 %	$ 2.07 B	USA
DermTech DMTK	80.6	-	-11.32 %	$ 2.94 M	USA
National Research Corporation NRC	29.4	$ 17.33	0.99 %	$ 388 M	USA
Natera NTRA	81.5	$ 204.87	-1.5 %	$ 20.2 B	USA
Biodesix BDSX	41.7	$ 15.36	1.92 %	$ 1.99 B	USA
Enzo Biochem ENZ	50.3	-	-8.98 %	$ 14.8 K	USA
Pacific Biosciences of California PACB	71.8	$ 1.42	5.97 %	$ 426 M	USA
Precipio PRPO	21.1	$ 25.98	1.64 %	$ 41.7 M	USA
Personalis PSNL	55.8	$ 6.58	-	$ 390 M	USA
RadNet RDNT	34.5	$ 55.06	0.49 %	$ 4.14 B	USA
Senseonics Holdings SENS	10.3	$ 6.69	-3.04 %	$ 279 M	USA
Sotera Health Company SHC	43.9	$ 14.87	-0.6 %	$ 4.22 B	USA
Heska Corporation HSKA	40.8	-	-	$ 1.31 B	USA
HTG Molecular Diagnostics HTGM	101	-	-20.0 %	$ 1.06 M	USA
Soleno Therapeutics SLNO	27	$ 52.25	32.31 %	$ 2.66 B	USA
Neuronetics STIM	48.7	$ 1.76	15.79 %	$ 116 M	USA
Thermo Fisher Scientific TMO	70	$ 488.19	-0.67 %	$ 184 B	USA